In a bombshell revelation that's rocking South African rugby, Lions CEO Rudolf Straeuli has announced the launch of an internal investigation following Springboks prop Asenathi Ntlabakanye's positive test for a banned substance. The drug, prescribed by a sports doctor for a health issue earlier this year, has thrust Ntlabakanye into the eye of a doping storm, sidelining him from upcoming Tests against the All Blacks in New Zealand.
Last Sunday, the South African Rugby Union (SARU) confirmed the shocking news of Ntlabakanye's drug test results, leading to his exclusion from the national team by Boks coach Rassie Erasmus for crucial matches in Auckland and Wellington. Despite the controversy, the substance detected was not deemed performance-enhancing and was prescribed for legitimate medical reasons, raising questions about the fairness of the ensuing fallout.
"Ntlabakanye was transparent in his declarations, acted in good faith and at all times followed the medical due process as prescribed by the industry," stated a SARU press release.
The player himself disputes any wrongdoing, backed by claims that he adhered to medical advice without any intention of gaining an unfair advantage. SAIDS chief executive Khalid Galant explained, "Because the substance is a so-called specified substance, a provisional suspension is not enforceable by SAIDS." This distinction spares Ntlabakanye an immediate suspension but doesn't clear him of potential sanctions.
Despite not opting to test his B sample, Ntlabakanye is gearing up for a legal battle, supported by a robust legal team poised to defend his case. The substance must meet two of three criteria—enhancing performance, being harmful to health, or violating the spirit of the sport—to warrant inclusion on the banned list, a point that will likely be central in his defense.
Galant hinted that a trial date could be announced soon, where Ntlabakanye will need to prove the unintentional ingestion of the banned substance. The prop, who has appeared three times for the Springboks, including memorable matches against Italy and the Wallabies, faces a crucial period where his career hangs in balance, potentially leading to a suspension if found liable.
As the rugby world watches, the case of Asenathi Ntlabakanye not only challenges individual accountability but also casts a spotlight on the responsibilities of medical professionals in sports. With his trial looming, the rugby community awaits clarity on an issue that could redefine protocols around player health management and substance control.
2,193 posts
In a bombshell revelation that's rocking South African rugby, Lions CEO Rudolf Straeuli has announced the launch of an internal investigation following Springboks prop Asenathi Ntlabakanye's positive test for a banned substance. The drug, prescribed by a sports doctor for a health issue earlier this year, has thrust Ntlabakanye into the eye of a doping storm, sidelining him from upcoming Tests against the All Blacks in New Zealand.
Last Sunday, the South African Rugby Union (SARU) confirmed the shocking news of Ntlabakanye's drug test results, leading to his exclusion from the national team by Boks coach Rassie Erasmus for crucial matches in Auckland and Wellington. Despite the controversy, the substance detected was not deemed performance-enhancing and was prescribed for legitimate medical reasons, raising questions about the fairness of the ensuing fallout.
"Ntlabakanye was transparent in his declarations, acted in good faith and at all times followed the medical due process as prescribed by the industry," stated a SARU press release.
The player himself disputes any wrongdoing, backed by claims that he adhered to medical advice without any intention of gaining an unfair advantage. SAIDS chief executive Khalid Galant explained, "Because the substance is a so-called specified substance, a provisional suspension is not enforceable by SAIDS." This distinction spares Ntlabakanye an immediate suspension but doesn't clear him of potential sanctions.
Despite not opting to test his B sample, Ntlabakanye is gearing up for a legal battle, supported by a robust legal team poised to defend his case. The substance must meet two of three criteria—enhancing performance, being harmful to health, or violating the spirit of the sport—to warrant inclusion on the banned list, a point that will likely be central in his defense.
Galant hinted that a trial date could be announced soon, where Ntlabakanye will need to prove the unintentional ingestion of the banned substance. The prop, who has appeared three times for the Springboks, including memorable matches against Italy and the Wallabies, faces a crucial period where his career hangs in balance, potentially leading to a suspension if found liable.
As the rugby world watches, the case of Asenathi Ntlabakanye not only challenges individual accountability but also casts a spotlight on the responsibilities of medical professionals in sports. With his trial looming, the rugby community awaits clarity on an issue that could redefine protocols around player health management and substance control.